KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Name: KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
License: Public Domain

Corregene Biotechnology Co., Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

colorectal, pancreatic, non-small cell lung cancer (nsclc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 414486
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.